Serologic differences between dermatomyositis and antisynthetase syndrome using a commercially available autoantibody panel: A retrospective cohort study - 19/07/23
Doi : 10.1016/j.jaad.2023.06.035
Neha Narayan, BA a, Christopher T. Richardson, MD, PhD b, ⁎ 
a University of Rochester School of Medicine and Dentistry, Rochester, New York
b Department of Dermatology, University of Rochester Medical Center, Rochester, New York
∗Correspondence to: Christopher T. Richardson, MD, PhD, URMC Department of Dermatology, 601 Elmwood Ave, Box 697, Rochester, NY 14642URMC Department of Dermatology601 Elmwood Ave, Box 697RochesterNY14642
En prensa. Pruebas corregidas por el autor.
Disponible en línea desde el Wednesday 19 July 2023
This article has been published in an issue click here to access
This article has been published in an issue click here to access
Key words : antinuclear antibody, antisynthetase syndrome, autoantibody, dermatomyositis, idiopathic inflammatory myopathy, myositis specific antibody
| Funding sources: None. |
|
| IRB approval status: Reviewed and approved by the University of Rochester Medical Center Institutional Review Board; approval #6217. |
© 2023
American Academy of Dermatology, Inc.. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?